Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
In this podcast, Michael Reid, MD, from University of California, San Francisco, discusses the newest HIV-TB prevention therapies, the latest research on a new tuberculosis vaccine, and more.
All patients taking pre-exposure prophylaxis for HIV should be tested regularly. Which is the preferred testing method for individuals starting or restarting PrEP for HIV?
Consultant360 spoke with Keith Horvath, PhD, about his study, which indicated that technology-assisted HIV testing interventions could serve as a key strategy in reaching national and global targets for HIV...
In this podcast, Michael Reid, MD, from University of California, San Francisco, discusses the newest HIV-TB prevention therapies, the latest research on a new tuberculosis vaccine, and more.
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.
In this Q&A, Monica Gandhi, MD, MPH, discusses interventions to address the health care disparities that exist along the care continuum for certain patient populations who are at-risk for HIV...
In this video, Jeffrey Kwong, DNP, MPH, ANP-BC, discusses the under-utilization of HIV pre-exposure prophylaxis (PrEP) and the integral role primary care providers play in screening and identifying...